Copyright Reports & Markets. All rights reserved.

Global Hyperthyroidism Medications Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hyperthyroidism Medications Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Methimazole
    • 1.3.3 Propylthiouracil
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hyperthyroidism Medications Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Hyperthyroidism Medications Market Size & Forecast
    • 1.5.1 Global Hyperthyroidism Medications Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Hyperthyroidism Medications Sales Quantity (2021-2032)
    • 1.5.3 Global Hyperthyroidism Medications Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Hyperthyroidism Medications Product and Services
    • 2.1.4 Merck Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Herbrand PharmaChemicals
    • 2.2.1 Herbrand PharmaChemicals Details
    • 2.2.2 Herbrand PharmaChemicals Major Business
    • 2.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Product and Services
    • 2.2.4 Herbrand PharmaChemicals Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Herbrand PharmaChemicals Recent Developments/Updates
  • 2.3 Shanghai Zhaohui Pharmaceutical
    • 2.3.1 Shanghai Zhaohui Pharmaceutical Details
    • 2.3.2 Shanghai Zhaohui Pharmaceutical Major Business
    • 2.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product and Services
    • 2.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
  • 2.4 Beijing Yanjing Pharmaceutical
    • 2.4.1 Beijing Yanjing Pharmaceutical Details
    • 2.4.2 Beijing Yanjing Pharmaceutical Major Business
    • 2.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product and Services
    • 2.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
  • 2.5 Jinghua Pharmaceutical Group
    • 2.5.1 Jinghua Pharmaceutical Group Details
    • 2.5.2 Jinghua Pharmaceutical Group Major Business
    • 2.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Product and Services
    • 2.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Jinghua Pharmaceutical Group Recent Developments/Updates
  • 2.6 Guangzhou Kanghe Pharmaceutical
    • 2.6.1 Guangzhou Kanghe Pharmaceutical Details
    • 2.6.2 Guangzhou Kanghe Pharmaceutical Major Business
    • 2.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product and Services
    • 2.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
  • 2.7 Zigong Honghe Pharmaceutical
    • 2.7.1 Zigong Honghe Pharmaceutical Details
    • 2.7.2 Zigong Honghe Pharmaceutical Major Business
    • 2.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product and Services
    • 2.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
  • 2.8 Guangdong Huanan Pharmaceutical
    • 2.8.1 Guangdong Huanan Pharmaceutical Details
    • 2.8.2 Guangdong Huanan Pharmaceutical Major Business
    • 2.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product and Services
    • 2.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
  • 2.9 Zibo Wankang Pharmaceutical Chemical
    • 2.9.1 Zibo Wankang Pharmaceutical Chemical Details
    • 2.9.2 Zibo Wankang Pharmaceutical Chemical Major Business
    • 2.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product and Services
    • 2.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
  • 2.10 Qilu Pharmaceutical
    • 2.10.1 Qilu Pharmaceutical Details
    • 2.10.2 Qilu Pharmaceutical Major Business
    • 2.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Product and Services
    • 2.10.4 Qilu Pharmaceutical Hyperthyroidism Medications Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Qilu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Hyperthyroidism Medications by Manufacturer

  • 3.1 Global Hyperthyroidism Medications Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hyperthyroidism Medications Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hyperthyroidism Medications Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hyperthyroidism Medications by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hyperthyroidism Medications Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hyperthyroidism Medications Manufacturer Market Share in 2025
  • 3.5 Hyperthyroidism Medications Market: Overall Company Footprint Analysis
    • 3.5.1 Hyperthyroidism Medications Market: Region Footprint
    • 3.5.2 Hyperthyroidism Medications Market: Company Product Type Footprint
    • 3.5.3 Hyperthyroidism Medications Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hyperthyroidism Medications Market Size by Region
    • 4.1.1 Global Hyperthyroidism Medications Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hyperthyroidism Medications Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hyperthyroidism Medications Average Price by Region (2021-2032)
  • 4.2 North America Hyperthyroidism Medications Consumption Value (2021-2032)
  • 4.3 Europe Hyperthyroidism Medications Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hyperthyroidism Medications Consumption Value (2021-2032)
  • 4.5 South America Hyperthyroidism Medications Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hyperthyroidism Medications Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Hyperthyroidism Medications Sales Quantity by Type (2021-2032)
  • 5.2 Global Hyperthyroidism Medications Consumption Value by Type (2021-2032)
  • 5.3 Global Hyperthyroidism Medications Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hyperthyroidism Medications Sales Quantity by Application (2021-2032)
  • 6.2 Global Hyperthyroidism Medications Consumption Value by Application (2021-2032)
  • 6.3 Global Hyperthyroidism Medications Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hyperthyroidism Medications Sales Quantity by Type (2021-2032)
  • 7.2 North America Hyperthyroidism Medications Sales Quantity by Application (2021-2032)
  • 7.3 North America Hyperthyroidism Medications Market Size by Country
    • 7.3.1 North America Hyperthyroidism Medications Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hyperthyroidism Medications Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hyperthyroidism Medications Sales Quantity by Type (2021-2032)
  • 8.2 Europe Hyperthyroidism Medications Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hyperthyroidism Medications Market Size by Country
    • 8.3.1 Europe Hyperthyroidism Medications Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hyperthyroidism Medications Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hyperthyroidism Medications Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Hyperthyroidism Medications Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hyperthyroidism Medications Market Size by Region
    • 9.3.1 Asia-Pacific Hyperthyroidism Medications Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hyperthyroidism Medications Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hyperthyroidism Medications Sales Quantity by Type (2021-2032)
  • 10.2 South America Hyperthyroidism Medications Sales Quantity by Application (2021-2032)
  • 10.3 South America Hyperthyroidism Medications Market Size by Country
    • 10.3.1 South America Hyperthyroidism Medications Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hyperthyroidism Medications Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hyperthyroidism Medications Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Hyperthyroidism Medications Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hyperthyroidism Medications Market Size by Country
    • 11.3.1 Middle East & Africa Hyperthyroidism Medications Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hyperthyroidism Medications Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hyperthyroidism Medications Market Drivers
  • 12.2 Hyperthyroidism Medications Market Restraints
  • 12.3 Hyperthyroidism Medications Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hyperthyroidism Medications and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hyperthyroidism Medications
  • 13.3 Hyperthyroidism Medications Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hyperthyroidism Medications Typical Distributors
  • 14.3 Hyperthyroidism Medications Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hyperthyroidism Medications market size was valued at US$ 561 million in 2025 and is forecast to a readjusted size of US$ 845 million by 2032 with a CAGR of 6.1% during review period.
    Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Hyperthyroidism Medications market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hyperthyroidism Medications market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hyperthyroidism Medications market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hyperthyroidism Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Hyperthyroidism Medications market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hyperthyroidism Medications
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hyperthyroidism Medications market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical, Zibo Wankang Pharmaceutical Chemical, Qilu Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hyperthyroidism Medications market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Methimazole
    Propylthiouracil
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Merck
    Herbrand PharmaChemicals
    Shanghai Zhaohui Pharmaceutical
    Beijing Yanjing Pharmaceutical
    Jinghua Pharmaceutical Group
    Guangzhou Kanghe Pharmaceutical
    Zigong Honghe Pharmaceutical
    Guangdong Huanan Pharmaceutical
    Zibo Wankang Pharmaceutical Chemical
    Qilu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hyperthyroidism Medications product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hyperthyroidism Medications, with price, sales quantity, revenue, and global market share of Hyperthyroidism Medications from 2021 to 2026.
    Chapter 3, the Hyperthyroidism Medications competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hyperthyroidism Medications breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hyperthyroidism Medications market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hyperthyroidism Medications.
    Chapter 14 and 15, to describe Hyperthyroidism Medications sales channel, distributors, customers, research findings and conclusion.

    Buy now